4//SEC Filing
KOCH KEVIN 4
Accession 0001562180-25-001025
CIK 0001710072other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:38 PM ET
Size
18.3 KB
Accession
0001562180-25-001025
Insider Transaction Report
Form 4
KOCH KEVIN
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-02-05−8,636→ 42,545 totalExercise: $0.18From: 2021-06-13Exp: 2027-08-08→ Common Stock (8,636 underlying) - Exercise/Conversion
Common Stock
2025-02-06$13.11/sh+900$11,799→ 15,378 total - Sale
Common Stock
2025-02-06$31.13/sh−900$28,018→ 14,478 total - Exercise/Conversion
Common Stock
2025-02-05$0.18/sh+8,636$1,554→ 23,114 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-06−900→ 41,645 totalExercise: $0.18From: 2021-06-13Exp: 2027-08-08→ Common Stock (900 underlying) - Sale
Common Stock
2025-02-05$30.03/sh−8,636$259,298→ 14,478 total
Holdings
- 259,554(indirect: By LLC)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
Footnotes (7)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024.
- [F2]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.03 to $30.1311, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]These shares are held directly by the KTK Family Enterprise, LLC for the which the Reporting Person serves as Manager.
- [F5]These shares are held directly by the Nicole M. Soldow Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
- [F6]These shares are held directly by the Adrienne R. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
- [F7]These shares are held directly by the Matthew K. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001185829
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:38 PM ET
- Size
- 18.3 KB